Snoring, subways and stealth ads: how big pharma targets China’s waistline
Weight-loss drugmakers are promoting obesity awareness in metro stations, exercise studios and soccer stadiums in China to target consumers, as local restrictions prevent direct advertising of prescription medicines.
Intelligence analysis by Llama
Big pharma companies are using stealth advertising to target China's growing obesity problem, as local restrictions prevent direct advertising of prescription medicines. They are promoting obesity awareness in metro stations, exercise studios and soccer stadiums.
Big pharma companies are using sneaky ads to help people in China lose weight. They're putting up posters in metro stations and exercise studios to remind people to eat healthy and exercise. This way, they can sell their weight-loss medicines without breaking the rules.
Analysis
China's Obesity Epidemic
China's rate of overweight or obese people could reach more than 65% by 2030, according to the country's National Health Commission. This has created a huge market for weight-loss drugs, with companies like Novo Nordisk, Eli Lilly, Pfizer, and local firm Innovent Biologics competing for market share with their versions of once-weekly GLP-1 weight-loss injections.
Stealth Advertising
Local restrictions prevent the direct advertising of prescription medicines in China, so these companies are using stealth advertising to reach their target audience. They are promoting obesity awareness in metro stations, exercise studios, and soccer stadiums, where people are more likely to see their ads. For example, Lilly led the once-weekly GLP-1 sales on Alibaba's Tmall e-commerce platform and JD.com in the second quarter, according to Jefferies.
The Impact
The impact of this stealth advertising is significant. It allows big pharma companies to reach their target audience without violating local regulations. However, it also raises concerns about the accuracy and transparency of the information being presented to consumers. As the market for weight-loss drugs continues to grow, it is essential that companies prioritize the health and well-being of their customers.
Key points
- Big pharma companies are using stealth advertising to target China's growing obesity problem.
- Local restrictions prevent the direct advertising of prescription medicines in China.
- Companies are promoting obesity awareness in metro stations, exercise studios, and soccer stadiums.
- The market for weight-loss drugs is growing rapidly in China.
- The impact of stealth advertising on consumer health outcomes is unclear.
If the trend of stealth advertising continues, it could lead to more innovative and effective ways for big pharma companies to reach their target audience. This could result in better health outcomes for consumers and increased market share for the companies.
However, the lack of transparency and accuracy in stealth advertising could lead to consumers making uninformed decisions about their health. This could result in negative health outcomes and damage to the reputation of big pharma companies.